GLENMARK PHARMACEUTICALS LTD. - Disclosure Pursuant To Regulation 30(7) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
12 Mar 2024
Disclosure pursuant to Regulation 30(7) of SEBI (LODR) Regulations, 2015 is attached.
Source:
BSE India